Recently added

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review

Balconi, Francesca; Garcia-Alvarez, Alejandro; Hernando, Jorge; OConnor, Juan Manuel; Chacon, Matias; Tissera, Natalia Soledad; Capdevila Castillon, Jaume (Elsevier, 2025-01)

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

Fracassi, Giulia; Lorenzin, Francesca; Orlando, Francesco; Gioia, Ubaldo; D'Amato, Giacomo; Solé Casaramona, Arnau; Mateo, Joaquin (American Society for Clinical Investigation, 2025)

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research

Amaral, Teresa; Nanz, Lena; Serna-Higuita, Lina Maria; Berking, Carola; ASCIERTO, PAOLO ANTONIO; MUÑOZ COUSELO, EVA (Elsevier, 2025-01)

A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)

Staehler, Michael; Basso, Umberto; Eymard, Jean-Christophe; Barthelemy, Philippe; Bigot, Pierre; LARAMAS, Mathieu; Suárez, Cristina (Elsevier, 2025-02)

Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer

Müller, Volkmar; de Azambuja, Evandro; Gempt, Jens; Bachelot, Thomas; Curigliano, Giuseppe; Furtner, Julia; Saura Manich, Cristina (Elsevier, 2025-01)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research

A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)

Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review ﻿

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer ﻿

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research ﻿

A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE) ﻿

Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer ﻿

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research

A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)

Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer